90 related articles for article (PubMed ID: 21946149)
1. Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis.
Walter R; Wanninger J; Bauer S; Eisinger K; Neumeier M; Weiss TS; Amann T; Hellerbrand C; Schäffler A; Schölmerich J; Buechler C
Exp Mol Pathol; 2011 Dec; 91(3):740-4. PubMed ID: 21946149
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes.
Wanninger J; Neumeier M; Bauer S; Weiss TS; Eisinger K; Walter R; Dorn C; Hellerbrand C; Schäffler A; Buechler C
FEBS Lett; 2011 May; 585(9):1338-44. PubMed ID: 21496456
[TBL] [Abstract][Full Text] [Related]
3. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells.
Suk FM; Chen CH; Lin SY; Cheng CJ; Yen SJ; Hung LF; Liu DZ; Liang YC
Toxicol Lett; 2009 May; 187(1):22-7. PubMed ID: 19429239
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
[TBL] [Abstract][Full Text] [Related]
5. Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions.
Schieren G; Gambichler T; Skrygan M; Burkert B; Altmeyer P; Rump LC; Kreuter A
Am J Kidney Dis; 2010 Jun; 55(6):1040-9. PubMed ID: 20430497
[TBL] [Abstract][Full Text] [Related]
6. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling.
Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
Hepatology; 2009 Jun; 49(6):2021-30. PubMed ID: 19309720
[TBL] [Abstract][Full Text] [Related]
8. Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes.
Wanninger J; Neumeier M; Hellerbrand C; Schacherer D; Bauer S; Weiss TS; Huber H; Schäffler A; Aslanidis C; Schölmerich J; Buechler C
Biochim Biophys Acta; 2011 Oct; 1811(10):626-33. PubMed ID: 21070865
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of connective tissue growth factor/CCN2 expression in human dermal fibroblasts by interleukin-1alpha and beta.
Nowinski D; Koskela A; Kiwanuka E; Boström M; Gerdin B; Ivarsson M
J Cell Biochem; 2010 Aug; 110(5):1226-33. PubMed ID: 20544797
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways.
Gressner OA; Lahme B; Rehbein K; Siluschek M; Weiskirchen R; Gressner AM
J Hepatol; 2008 Nov; 49(5):758-67. PubMed ID: 18486259
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.
Gressner OA; Gressner AM
Liver Int; 2008 Sep; 28(8):1065-79. PubMed ID: 18783549
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro.
Neumeier M; Weigert J; Schäffler A; Weiss TS; Schmidl C; Büttner R; Bollheimer C; Aslanidis C; Schölmerich J; Buechler C
Biochem Biophys Res Commun; 2006 Nov; 350(3):731-5. PubMed ID: 17022944
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.
Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435
[TBL] [Abstract][Full Text] [Related]
14. MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis.
Wanninger J; Walter R; Bauer S; Eisinger K; Schäffler A; Dorn C; Weiss TS; Hellerbrand C; Buechler C
Exp Mol Pathol; 2011 Oct; 91(2):603-7. PubMed ID: 21791204
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta/connective tissue growth factor axis in the kidney.
Qi W; Chen X; Poronnik P; Pollock CA
Int J Biochem Cell Biol; 2008; 40(1):9-13. PubMed ID: 17300978
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
Nan YM; Fu N; Wu WJ; Liang BL; Wang RQ; Zhao SX; Zhao JM; Yu J
Scand J Gastroenterol; 2009; 44(3):358-65. PubMed ID: 18991162
[TBL] [Abstract][Full Text] [Related]
17. Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells.
Gressner OA; Lahme B; Siluschek M; Gressner AM
Liver Int; 2009 Jul; 29(6):886-97. PubMed ID: 19291178
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
19. Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression.
Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
Liver Int; 2008 Nov; 28(9):1207-16. PubMed ID: 18397232
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.
Wanninger J; Bauer S; Eisinger K; Weiss TS; Walter R; Hellerbrand C; Schäffler A; Higuchi A; Walsh K; Buechler C
Mol Cell Endocrinol; 2012 Feb; 349(2):248-54. PubMed ID: 22118966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
